Dambkowski Carl
- SEC CIK
- 0001983476
In the past year, 14 open-market sale filings worth $18.8M and no purchases.
Current role at each company
- APGE Apogee Therapeutics, Inc.Chief Medical Officeras of Sep 3, 2026
- ORKA Oruka Therapeutics, Inc.Directoras of Jun 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $18.8M
- 14 filings
- Net
- −$18.8M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Dambkowski Carl as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
APGE Apogee Therapeutics, Inc.
Chief Medical Officer28 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 (view filing)8:00 PM ET | Aug 5 | 2 days | Dambkowski CarlChief Medical Officer | SSale | −5.50K | $134.17 | −$737.9K | −3.2%168.5K after | 10b5-1 |
| Jul 2, 2026 (view filing)8:13 PM ET | Jul 1 | 1 day | Dambkowski CarlChief Medical Officer | SSale | −5.50K | $132.74 | −$730.1K | −3.0%177.9K after | 10b5-1 |
| Jun 24, 2026 (view filing) | Jun 22 | 2 days | Dambkowski CarlChief Medical Officer | SSale | −26.4K | $132.60 | −$3.50M | −12.8%179.2K after | 10b5-1 |
| Jun 5, 2026 (view filing) | Jun 3 | 2 days | Dambkowski CarlChief Medical Officer | SSale | −5.50K | $78.71 | −$432.9K | −2.6%205.6K after | 10b5-1 |
| May 8, 2026 (view filing) | May 6 | 2 days | Dambkowski CarlChief Medical Officer | SSale | −5.50K | $84.14 | −$462.8K | −2.6%207.0K after | 2 lots10b5-1 |
| Apr 3, 2026 (view filing) | Apr 1 | 2 days | Dambkowski CarlChief Medical Officer | SSale | −5.50K | $84.84 | −$466.6K | −2.6%208.4K after | 3 lots10b5-1 |
| Mar 6, 2026 (view filing) | Mar 4 | 2 days | Dambkowski CarlChief Medical Officer | SSale | −5.50K | $71.06 | −$390.8K | −2.6%209.8K after | 3 lots10b5-1 |
| Feb 4, 2026 (view filing) | Feb 4 | Same day | Dambkowski CarlChief Medical Officer | SSale | −5.50K | $65.79 | −$361.9K | −2.5%211.1K after | 5 lots10b5-1 |
| Jan 9, 2026 (view filing) | Jan 7 | 2 days | Dambkowski CarlChief Medical Officer | SSale | −18.7K | $77.84 | −$1.46M | −8.1%212.5K after | 4 lots10b5-1 |
| Dec 5, 2025 (view filing) | Dec 4 | 1 day | Dambkowski CarlChief Medical Officer | SSale | −10.9K | $75.00 | −$817.5K | −3.9%271.1K after | 10b5-1 |
ORKA Oruka Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 (view filing) | Jun 11-12 | 1 day | Dambkowski CarlDirector | SSale | −35.0K | $70.12 | −$2.45M | −47.5%38.7K after | 2 lots10b5-1 |
| May 22, 2026 (view filing) | May 21 | 1 day | Dambkowski CarlDirector | SSale | −105.0K | $58.97 | −$6.19M | −58.7%73.7K after | 3 lots10b5-1 |